Mail

Australia markets closed

ALL ORDS
7,709.50
+21.50(+0.28%)
ASX 200
7,493.80
+25.50(+0.34%)
AUD/USD
0.7106
-0.0011(-0.15%)
OIL
79.38
-1.63(-2.01%)
GOLD
1,927.60
-2.40(-0.12%)
BTC-AUD
32,310.31
+64.47(+0.20%)

📩 Sign up now

News that makes you smarter and richer... For free.

Get Fully Briefed with Yahoo Finance, delivered straight to your inbox.

Microba Life Sciences Limited (MAP.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.3250

+0.0100

(+3.17%)

At close: 03:03PM AEDT

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	113.17M
Enterprise value	83.92M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	15.70
Price/book (mrq)	3.37
Enterprise value/revenue	17.90
Enterprise value/EBITDA	-8.47

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-7.14%
S&P500 52-week change ³	-8.38%
52-week high ³	0.4500
52-week low ³	0.1350
50-day moving average ³	0.3099
200-day moving average ³	0.2567

Share statistics

Avg vol (3-month) ³	245.02k
Avg vol (10-day) ³	46.66k
Shares outstanding ⁵	342.95M
Implied shares outstanding ⁶	N/A
Float ⁸	178.94M
% held by insiders ¹	55.04%
% held by institutions ¹	21.43%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 June 2022
Most-recent quarter (mrq)	30 June 2022

Profitability

Profit margin	-244.64%
Operating margin (ttm)	-347.05%

Management effectiveness

Return on assets (ttm)	-35.09%
Return on equity (ttm)	-47.33%

Income statement

Revenue (ttm)	4.69M
Revenue per share (ttm)	0.02
Quarterly revenue growth (yoy)	22.10%
Gross profit (ttm)	2.37M
EBITDA	-15.56M
Net income avi to common (ttm)	-11.47M
Diluted EPS (ttm)	-0.0550
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	30.79M
Total cash per share (mrq)	0.11
Total debt (mrq)	1.33M
Total debt/equity (mrq)	3.95
Current ratio (mrq)	6.80
Book value per share (mrq)	0.12

Cash flow statement

Operating cash flow (ttm)	-10.45M
Levered free cash flow (ttm)	-10.46M